{"nctId":"NCT02949674","briefTitle":"Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients","startDateStruct":{"date":"2016-09"},"conditions":["Ankle Fractures","Pain, Postoperative","Local Infiltration"],"count":93,"armGroups":[{"label":"Bupivacaine","type":"EXPERIMENTAL","interventionNames":["Drug: Bupivacaine"]},{"label":"Ropivacaine","type":"EXPERIMENTAL","interventionNames":["Drug: Ropivacaine"]},{"label":"Control","type":"NO_INTERVENTION","interventionNames":[]}],"interventions":[{"name":"Ropivacaine","otherNames":["Naropin"]},{"name":"Bupivacaine","otherNames":["Bupivacaine hydrochloride"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient with afiliation to IMSS\n* Patient with ankle fracture that requires surgical treatment with open reduction and internal fixation\n* Patient that accept to participate in the study whit a sign of document.\n\nExclusion Criteria:\n\n* Politrauma patients (Patients with another fracture)\n* Patients who dont accept to participate in the study\n* Neuropathy in inferior limps that limits pain perception\n* Open ankle fractures","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"VAS","description":"The Pain will be measured with this scale from 0 (No pain) -10 (Worst pain possible) according to the investigator at 24 hours after surgery.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.81","spread":"1.302"},{"groupId":"OG001","value":"2.13","spread":"0.619"},{"groupId":"OG002","value":"3.52","spread":"1.387"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.52","spread":"1.022"},{"groupId":"OG001","value":"3.04","spread":"1.113"},{"groupId":"OG002","value":"5.02","spread":"0.957"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.42","spread":"0.765"},{"groupId":"OG001","value":"3.55","spread":"0.995"},{"groupId":"OG002","value":"4.84","spread":"1.061"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.03","spread":"0.836"},{"groupId":"OG001","value":"3.87","spread":"0.783"},{"groupId":"OG002","value":"4.10","spread":"0.831"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":[]}}}